RPR/Fisons plc
After enjoying several decades of fast profit growth the pharmaceutical industry is under threat. Research & Development costs are outstripping the return on investment, many of the best selling drugs are reaching the end of their 20 year patent protection period and there is the increasing threat of regulatory reform. Against this background Fisons plc (Fisons), a medium sized UK pharmaceutical company, is struggling. A new Chief Executive Officer is appointed. The third in three years. In his attempt to revive Fisons he is forced to adopt a radical programme of reform. His harsh medicine appears to be working when Fisons becomes the target of a hostile take-over bid from Rhtne-Poulenc Rorer Inc. (RPR), the giant French pharmaceutical company. Is Fisons able to fight off this bid and remain independent?
1995
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
The idea of an EU bond, a common safe asset, has been gaining attention lately, particularly following calls for its introduction this month by former Italian prime minister Mario Draghi.
In addition to traditional venture capital (VC), governmental VC and social impact VC investors have emerged as alternatives to fund entrepreneurial ventures, especially start-ups that incorporate social and/or environmental objectives into commer...
The call by the former Italian prime minister and ECB president for massive investment in the EU is a wake-up call to Europe's economic stagnation. But can the continent afford the trade-offs it is overlooking?
We study the effects of carbon transition risk on equity prices in the United States and Europe using disclosed carbon intensity data and find a negative effect on the cross section of returns and a negative carbon premium for the period 2009–2019...
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Finance Research Letters October 2024, vol. 68, 105987, https://doi.org/10.1016/j.frl.2024.105987
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 18 September 2024
Research Information & Knowledge Hub for additional information on IMD publications
in The Financial Review 16 September 2024, ePub before print, https://doi.org/10.1111/fire.12414
Research Information & Knowledge Hub for additional information on IMD publications